19 Harley St, London, W1G 9QJ, UK

Effect of pioglitazone on insulin resistance, progression of atherosclerosis and clinical course of coronary heart disease.

Related Articles

Effect of pioglitazone on insulin resistance, progression of atherosclerosis and clinical course of coronary heart disease.

Wiad Lek. 2017;70(5):881-890

Authors: Skochko OV, Kaidashev IP

INTRODUCTION: Pioglitazone, a medication of thiazolidinedione group, is capable of triggering the peroxisome proliferator-activated receptors (PPAR-?). Activation of receptor PPAR-? regulates carbohydrate and lipid metabolism, immune and inflammatory responses in heart tissues.
THE AIM: Our aim was to study the effect of pioglitazone on insulin resistance, the clinical course of atherosclerosis and coronary heart disease (CHD).
MATERIALS AND METHODS: The study included 43 patients with coronary artery disease. Patients were divided into the main group – 20 patients, in whom pioglitazone (Pioglar, Ranbaxy, India) was included in the combined therapy at a dose of 15 mg 1 time per day in the morning, and the comparison group – 23 patients receiving standard complex drug therapy over 6 months. Patients underwent clinical examination, ultrasound of neck vessels, study of carbohydrate and lipid metabolism.
RESULTS: Joining pioglitazone to standard therapy resulted in the reduction of systolic (p<0.05) and diastolic (p<0.05) blood pressure; decrease in the duration of pain attacks (p<0.05); reduction in the frequency of angina attacks (p<0.05); regression of atherosclerosis of the carotid vessels (p<0.05), decrease in the thickness of the intima-media complex (p<0.05). The decline in oral glucose tolerance test (p<0.05), hyperglycemic factor (p<0.05), total cholesterol (p<0.05), and low density lipoproteins (p<0.05) were observed, as well as increased high-density lipoprotein (p<0.05).
CONCLUSION: Long-term treatment with pioglitazone at low doses against the background of standard therapy contributes to functional and clinical condition of patients, promotes the prevention of atherosclerosis and reduction of insulin resistance, thereby improving the clinical manifestations of coronary heart disease.

PMID: 29203734 [PubMed – in process]

Share to care...

Share on facebook
Share on twitter
Share on pinterest
Share on google
Share on linkedin
Share on skype

What we do...

The Harley Street Hospital


What is London spine unit and How it Works

The London Spine Unit was established in 2005 and has successfully treated over 5000 patients. All conditions are treated.

We treat all spinal disorders

The London Spine Unit specialises in Minimally Invasive Treatments allowing rapid recovery and return to normal function

Trusted by patients worldwide

The London Spine Unit provides the highest quality care to all patients and has VIP services for those seeking exceptional services

What our patients say about us ......

Transforaminal Epidural

Comfortable environment – all nurses, anaesthetist, doctor made me feel at ease. Paul S. You May Also Like:Caudal Epidural and Facet Joint InjectionsPatient suffering from

Read More »